Bortezomib for Injection recall in Canada: particulate matter risk
In plain language
This recall involves Bortezomib for Injection sold in Canada. It's being recalled because of the potential for glass particulate matter in affected lots. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot number 9501016.
- Contact Teva Canada Inc. for instructions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Bortezomib for Injection
Lot: 9501016
Why this matters
Risk of particulate matter (glass)
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 9501016
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Risk of particulate matter (glass)
What should consumers do?
Stop using the product immediately. Check the lot number 9501016. Contact Teva Canada Inc. for instructions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Risk of particulate matter (glass)
When was this product recalled?
This product was recalled on April 19, 2018.